Intrapleural Photodynamic Therapy for Mesothelioma: What Place and Which Future?

Ann Thorac Surg. 2015 Jun;99(6):2237-45. doi: 10.1016/j.athoracsur.2014.12.077. Epub 2015 Apr 23.

Abstract

In the surgical multimodal management of malignant pleural mesothelioma, it seems crucial to proceed with an efficient local adjuvant treatment to kill residual tumor cells. Intrapleural photodynamic therapy has recently emerged as a potential candidate in this goal. In this review, we analyzed and classified 16 articles in which patients with malignant pleural mesothelioma received intrapleural photodynamic therapy after maximal surgical resection. The toxicity, effect on survival, and development of the technique were assessed. After two decades of clinical studies, intrapleural photodynamic therapy after surgical resection became a safe treatment that significantly improved the survival of patients.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Injections
  • Lung Neoplasms / drug therapy*
  • Mesothelioma / drug therapy*
  • Mesothelioma, Malignant
  • Photochemotherapy / methods
  • Photochemotherapy / trends*
  • Photosensitizing Agents / administration & dosage*
  • Pleural Cavity
  • Pleural Neoplasms / drug therapy*

Substances

  • Photosensitizing Agents